Bioventus Inc.
BVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$318 | -$121,196 | -$144,651 | $11,454 |
| Dep. & Amort. | $49,555 | $57,365 | $55,398 | $34,875 |
| Deferred Tax | -$5,394 | -$2,377 | -$46,658 | -$9,756 |
| Stock-Based Comp. | $10,058 | $2,722 | $17,585 | $19,844 |
| Change in WC | -$11,780 | -$3,181 | -$29,730 | -$15,145 |
| Other Non-Cash | -$3,326 | $82,011 | $134,519 | -$18,281 |
| Operating Cash Flow | $38,795 | $15,344 | -$13,537 | $22,991 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,006 | -$7,362 | -$1,478 | -$13,520 |
| Net Acquisitions | $0 | $34,675 | $0 | -$262,870 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $23,969 | -$11,506 | -$114,958 | -$7,370 |
| Investing Cash Flow | $22,963 | $15,807 | -$116,436 | -$283,760 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$59,584 | -$23,264 | $59,621 | $166,203 |
| Stock Issued | $2,442 | $778 | $5,822 | $109,410 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$367 |
| Other Fin. Act. | $2,562 | -$4,167 | -$3,367 | -$1,875 |
| Financing Cash Flow | -$54,580 | -$26,653 | $62,076 | $273,371 |
| Forex Effect | -$2,560 | $629 | $521 | -$228 |
| Net Chg. in Cash | $4,618 | $5,127 | -$67,376 | $12,374 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36,964 | $31,837 | $99,213 | $86,839 |
| End Cash | $41,582 | $36,964 | $31,837 | $99,213 |
| Free Cash Flow | $37,789 | $7,982 | -$15,015 | $2,101 |